Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
16.03
-0.90 (-5.32%)
At close: Sep 18, 2026, 4:00 PM EDT
16.10
+0.07 (0.44%)
After-hours: Sep 18, 2026, 7:33 PM EDT
ARCT Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, ARCT stock has a consensus rating of "Buy" and an average price target of $22.3. The average 1-year stock price forecast is 39.11% higher than the current stock price, while the lowest is $8.00 (-50.09%) and the highest is $41 (+155.77%).
Price Target: $22.3 (+39.11%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ARCT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 9 | 9 | 9 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 12 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Citi No rating | Citi | Hold Maintains $8 | Hold | Maintains | $8 | -50.09% | Sep 10, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $20 → $41 | Buy | Reiterates | $20 → $41 | +155.77% | Sep 2, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $20 | Buy | Maintains | $20 | +24.77% | Aug 20, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Maintains $9 | Hold | Maintains | $9 | -43.86% | Aug 11, 2026 |
| BTIG | BTIG | Buy Maintains $23 | Buy | Maintains | $23 | +43.48% | Aug 10, 2026 |
Financial Forecast
Revenue This Year
18.64M
from 82.03M
Decreased by -77.28%
Revenue Next Year
29.58M
from 18.64M
Increased by 58.72%
EPS This Year
-3.42
from -2.40
EPS Next Year
-3.61
from -3.42
EPS and Forward PE are based on non-GAAP adjusted numbers.